Real world experience with pembrolizumab and nivolumab for treatment of non-small cell lung cancer (NSCLC) in an Irish Regional Cancer Center.

e21196Background: Immunotherapy (IO) has improved outcomes of advanced NSCLC patients in randomized clinical trials. Data on outcomes for these agents outside of a clinical trial setting in Ireland...